Product Information
AMPHETAMINE ER 18.8 MG ODT is a generic product labeled by Neos Therapeutics Brands, LLC, priced at $16.3166 per EA under NDC 62542003030. Its NADAC has been published 23 times since Jan 21, 2026.
Strength
18.8 mg/1
Manufacturer
Neos Therapeutics Brands, LLCNDC
62542003030
Classification
Generic
Dosage Form
TABLET, ORALLY DISINTEGRATING
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
AMPHETAMINEApproval Type
Authorized Generic (NDA)
FDA Application
NDA204326On Market Since
9/1/2025
Pharmacological Classes
Price Statistics
The NADAC for AMPHETAMINE ER 18.8 MG ODT has been published 23 times since Jan 21, 2026, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $16.3166 per EA |
|---|---|
| All-time high | $16.5172 (Feb 11, 2026) |
| All-time low | $16.3166 (Jun 17, 2026) |
| 52-week high | $16.5172 |
| 52-week low | $16.3166 |
| Median price | $16.3972 |
| Average price | $16.4027 |
| Largest weekly change | -0.8% (Apr 22, 2026) |
| Weeks tracked | 23 |
| Tracking since | Jan 21, 2026 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the Amphetamine Extended-Release market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of AMPHETAMINE ER 18.8 MG ODT?
The current National Average Drug Acquisition Cost (NADAC) for AMPHETAMINE ER 18.8 MG ODT, manufactured by Neos Therapeutics Brands, LLC, is $16.3166 per EA (NDC 62542003030), effective Jun 24, 2026.
How has the price of AMPHETAMINE ER 18.8 MG ODT changed over time?
Over the history we have for it, the NADAC for AMPHETAMINE ER 18.8 MG ODT has held within roughly two percent of its current level. It has been tracked across 23 weekly CMS publications since Jan 21, 2026.
What are the highest and lowest recorded NADAC prices for AMPHETAMINE ER 18.8 MG ODT?
Since Jan 21, 2026, the NADAC for AMPHETAMINE ER 18.8 MG ODT has ranged from a low of $16.3166 (Jun 17, 2026) to a high of $16.5172 (Feb 11, 2026), with a median of $16.3972 per EA.
Are there cheaper alternatives to AMPHETAMINE ER 18.8 MG ODT?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of AMPHETAMINE ER 18.8 MG ODT, so no direct lower-cost alternative is listed.
Who manufactures AMPHETAMINE ER 18.8 MG ODT?
AMPHETAMINE ER 18.8 MG ODT (NDC 62542003030) is labeled by Neos Therapeutics Brands, LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification